Predicting fetoplacental chromosomal mosaicism during non-invasive prenatal testing.
Nathalie BrisonMaria C NeofytouLuc DehaspeBaran BayindirKris Van Den BogaertLeila DardourHilde PeetersHilde Van EschGriet Van BuggenhoutAnnick VogelsThomy de RavelEric LegiusKoen DevriendtJoris R VermeeschPublished in: Prenatal diagnosis (2018)
This approach permits the non-invasive detection of fetal autosomal aneuploidies and identifies pregnancies with a high risk of fetoplacental mosaicism. Knowledge about the presence of chromosomal mosaicism in the placenta influences risk estimation, genetic counseling, and improves prenatal management.